FDA Lets Compounding Pharmacies Use Peptides | Savannah News

The FDA’s Pharmacy Compounding Advisory Committee just voted to allow compounding pharmacies to use certain peptides like BPC-157, KPV, and TB-500—claimed to help with gut health and healing—despite FDA scientists warning there’s insufficient evidence they’re safe or effective. The vote was tight: eight yes, six no. Supporters argued regulated access could steer patients away from dangerous online sources, while critics fear public perception might wrongly treat this as approval, especially since some studies show these peptides may be no better than placebos. Now, these peptides can be more easily obtained through compounding pharmacies, sparking a crucial debate about balancing alternative treatments with proven safety. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e5ea7ea92faea915